Molecules / Carboplatin / China

Carboplatin API manufacturers in China

CAS 41575-94-4 ATC L01XA02 Updated 9 July 2026
5
China-based manufacturers with an active filing of 12 worldwide
Showing 3 of 5 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

01

Qilu Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and one valid CEP for carboplatin, filing since 2010. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 7 markets.

US DMF
1 active
CEP
1 valid
Last FDA inspection
2025 · NAI
GMP recognised in
7 markets
How this listing is sourced EDQM certificate database
FDA, List of Drug Master Files
View profile
03

Registered with PMDA (Japan) for carboplatin.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

2 more manufacturers in China hold filings for carboplatin

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Kunming Guiyan PharmaceuticalShanghaiCdymaxPharmaceuticalsCo.,Ltd
Open the full list with a free account

How this list is built

This page filters the worldwide Carboplatin manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Map carboplatin for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

All Carboplatin manufacturers

Worldwide 12